At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06127 JOINN
Not Yet Opened 01-26 16:08:12
25.740
+0.080
+0.31%
High26.600
Low25.180
Vol3.39M
Open25.660
D1 Closing25.660
Amplitude5.53%
Mkt Cap19.28B
Tradable Cap3.06B
Total Shares749.00M
T/O87.81M
T/O Rate2.85%
Tradable Shares119.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
JOINN (06127) Controlling Shareholder Zhou Zhiwen Reduces Holdings by 10.1037 Million Shares
Hong Kong Stock Movement | JOINN (06127) Jumps Over 5% as Company Benefits from Soaring Prices of Lab Monkeys, Forecasts Net Profit Surge Exceeding 200% Last Year
Zhutong Hong Kong Stock Morning Briefing | National Healthcare Security Administration Issues "Guidelines for Pricing Medical Service Items for Surgical and Therapeutic Auxiliary Operations" National Winter Electricity Load Hits Third Record High in 2026
Hong Kong Stocks Movement | JOINN (06127) Surges Over 7%, Shares Up Nearly 60% in Past Month; Company Poised to Benefit from Monkey Price Fair Value Gains
Hong Kong Stocks Movement | CRO Concept Stocks Show Strong Performance, External Demand Recovery Clearly Reflected in Earnings, Domestic Demand Recovery Extends from Front-end to Back-end
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. The Company operates its businesses through three segments. The Non-clinical Drug Research Service segment mainly provides non-clinical drug safety evaluation services, pharmacodynamic research services, and pharmacokinetic research services. The Clinical Services and Others segment mainly provides pre-market clinical services and pharmacovigilance services for drugs. The Experimental Model Supply segment is responsible for the production and sales of experimental models and their ancillary products. The Company conducts its businesses both in the domestic market and overseas markets.